TATIANA MICHURA: Open Payments
NPI 1649755984 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 22 payments from 9 companies in 2025. Trend: 2023 $144 · 2024 $375 · 2025 $364
Food & beverage: $356Education: $8
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 13 | $183 |
| Novo Nordisk Inc | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: Qelbree, Rybelsus, COBENFY, INGREZZA, Jornay PM, The Cologuard Plus Collection Kit, VAXNEUVANCE, Saxenda.
Industry payments across MI — which companies pay providers there.
